Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UNC93B4 is classified as a human pseudogene and does not encode a functional protein. It should not be confused with UNC93B1, the endoplasmic reticulum-associated transmembrane protein essential for Toll-like receptor trafficking and activation in immune responses[3]. No data supports a druggable or biological role for UNC93B4 in human disease or therapy. Note: If information about "unc-93 homolog B4" was intended to refer to the immunologically relevant gene, the correct target is "unc-93 homolog B1 (UNC93B1)"[1][2]. UNC93B1 is a regulator of nucleic acid-sensing Toll-like receptors and involved in immune signaling, cancer, and susceptibility to infection, but UNC93B4 itself is a pseudogene with no therapeutic or known biological function in humans[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on unc-93 homolog B4 (pseudogene) (UNC93B4).